BackBellicum Pharmaceuticals Overview

Bellicum Pharmaceuticals Current Assets

Track Bellicum Pharmaceuticals's current assets ($6.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$6.85M
↓ 78.10% YoYΔ $-24.42M vs prior year quarter

Peer trimmed avg / median

Loading

Bellicum Pharmaceuticals Current Assets History

Loading

Bellicum Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Bellicum Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bellicum Pharmaceuticals (BLCM) FAQ

As of the most recent data (September 2023), BLCM shows a current assets of $6.8M. That compares with $31M in the prior-year period — down 78.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLCM's current assets is now $6.8M (was $31M) — a 78.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellicum Pharmaceuticals is outperforming or lagging.

Tracking BLCM's current assets over time shows whether Bellicum Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $6.8M That compares with $31M in the prior-year period — down 78.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Bellicum Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $6.8M) with ownership activity and broader fundamentals.

Bellicum Pharmaceuticals's current assets is $6.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.